# Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Study · id `cardio:ct-nct07222813` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07222813](<https://clinicaltrials.gov/study/NCT07222813>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07222813

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 149 participants.

## Technical summary

Registry record NCT07222813. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-04-23 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 149 participants (planned count; ClinicalTrials.gov record NCT07222813, source copy `cardio:ctgov-nct07222813-2026-09-23`, retrieved 2026-10-26)
- Started: 2026-04-23 (actual) (ClinicalTrials.gov record NCT07222813, source copy `cardio:ctgov-nct07222813-2026-09-23`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07222813, source copy `cardio:ctgov-nct07222813-2026-09-23`, retrieved 2026-10-26)
- Completion: 2028-01-15 (anticipated) (ClinicalTrials.gov record NCT07222813, source copy `cardio:ctgov-nct07222813-2026-09-23`, retrieved 2026-10-26)
- Countries: United States; France; Germany; Poland (ClinicalTrials.gov record NCT07222813, source copy `cardio:ctgov-nct07222813-2026-09-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07222813-2026-09-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
- Condition: Heart Failure
- Condition: Heart Failure - NYHA II - IV
- Intervention (Device): FibroScan
- Intervention (Procedure): Right-sided Heart Catheterization
- Intervention (Procedure): Transthoracic echocardiography
- Intervention (Biological): Blood Sample Analysis
- Lead sponsor: Echosens
- Lead sponsor class: INDUSTRY
- Collaborator: Syneos Health
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Syneos Health (`cardio:org-syneos-health`)

## Provenance

Content hash: c434ffec67fdc65db88da77625a7707820f60614420cf8e1bf9e751489c2eb45
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
